Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Oct 22, 2025. Filed Oct 22, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Oct 22, 2025 · Filed Oct 22, 2025

USNA$13.63-1.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · (in thousands, except per share data)

(in thousands, except per share data)

Quarter EndedNine months ended
September 27, 2025September 28, 2024September 27, 2025September 28, 2024
Net earnings (loss) attributable to USANA (GAAP)$(6,522)$10,607$12,535$37,576
Earnings (loss) per common share - Diluted (GAAP)$(0.36)$0.56$0.67$1.96
Weighted Average common shares outstanding - Diluted18,29319,08318,67119,181
Adjustment to net earnings (loss):
Transaction, integration and transition costs - Hiya$179$—$871$—
Inventory step-up - Hiya——1,126—
Amortization of intangible assets - Hiya4,455—13,366—
Adjustments to net earnings (loss) attributable to noncontrolling interest(941)—(3,066)—
Income tax effect of adjustments to net earnings (loss)——(4)—
Adjusted net earnings (loss) attributable to USANA$(2,829)$10,607$24,828$37,576
Adjusted earnings (loss) per common share - Diluted$(0.15)$0.56$1.33$1.96
Weighted average common shares outstanding - Diluted18,29319,08318,67119,181
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.